Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00051402 · ClinicalTrials.gov registry record · Phase 2
Phytoestrogens and Memory Decline in Menopause
A Phase 2 study of Memory Loss and Postmenopause, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT00051402: Completed Phase 2 study of Memory Loss and Postmenopause, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00051402 is a Phase 2 study of Memory Loss and Postmenopause that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 96 participants, below the 403-participant average among 12 other Memory Loss trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00051402, a Phase 2 study of Memory Loss and Postmenopause, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate whether soy-derived phytoestrogens taken as dietary supplements improve memory function in postmenopausal women who have experienced early memory decline.
Conditions Studied
Interventions
- DRUG Isoflavones
Study Locations (1)
Ohio
- University of Cincinnati College of Medicine - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2002-12 |
| Est. Completion | 2007-08 |
| Phase | Phase 2 |
What the finished NCT00051402 record still lists
NCT00051402 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 403-participant average among 12 other Memory Loss trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Memory Loss appearing as the primary indexed condition, and to 1 intervention - of which Isoflavones is the first listed.
NCT00051402 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00051402 about?
NCT00051402 is a clinical study titled "Phytoestrogens and Memory Decline in Menopause". The purpose of this study is to investigate whether soy-derived phytoestrogens taken as dietary supplements improve memory function in postmenopausal women who have experienced early memory decline.
What is the current status of trial NCT00051402?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 96 participants. The study started on 2002-12. Estimated completion is 2007-08.
What conditions does trial NCT00051402 study?
This clinical trial studies the following conditions: Memory Loss, Postmenopause.
What interventions are being tested in trial NCT00051402?
The interventions under investigation include: Isoflavones (DRUG).
Who is sponsoring clinical trial NCT00051402?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00051402 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Memory Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00051402's enrollment target sits among peer trials
96 9th of 12 higher than 4 of 12 other Memory Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Memory Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
RECRUITING
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Brain Health Virtual Reality Study
RECRUITING · NA
-
Targeted Transcranial Magnetic Stimulation to Improve Hippocampal-dependent Declarative Memory Abilities
RECRUITING · NA
-
Pharmacological Modulation of Brain Oscillations in Memory Processing
RECRUITING · Early Phase 1
-
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness Responses
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia